HRP20171573T1 - Čvrsti oblik derivata dihidro-pirido-oksazina - Google Patents

Čvrsti oblik derivata dihidro-pirido-oksazina Download PDF

Info

Publication number
HRP20171573T1
HRP20171573T1 HRP20171573TT HRP20171573T HRP20171573T1 HR P20171573 T1 HRP20171573 T1 HR P20171573T1 HR P20171573T T HRP20171573T T HR P20171573TT HR P20171573 T HRP20171573 T HR P20171573T HR P20171573 T1 HRP20171573 T1 HR P20171573T1
Authority
HR
Croatia
Prior art keywords
form according
anhydrous crystalline
crystalline form
therapeutically effective
pyrido
Prior art date
Application number
HRP20171573TT
Other languages
English (en)
Croatian (hr)
Inventor
Konstanze Hurth
Christoph KALIS
Karen KAMMERTOENS
Nicolas Soldermann
Frédéric ZECRI
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Priority claimed from EP13824177.3A external-priority patent/EP2928896B1/en
Publication of HRP20171573T1 publication Critical patent/HRP20171573T1/hr

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
HRP20171573TT 2012-11-26 2013-11-26 Čvrsti oblik derivata dihidro-pirido-oksazina HRP20171573T1 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GC201222895 2012-11-26
EP13824177.3A EP2928896B1 (en) 2012-11-26 2013-11-26 Solid form of dihydro-pyrido-oxazine derivative
PCT/IB2013/060412 WO2014102630A1 (en) 2012-11-26 2013-11-26 Solid form of dihydro-pyrido-oxazine derivative

Publications (1)

Publication Number Publication Date
HRP20171573T1 true HRP20171573T1 (hr) 2017-11-17

Family

ID=54198861

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20171573TT HRP20171573T1 (hr) 2012-11-26 2013-11-26 Čvrsti oblik derivata dihidro-pirido-oksazina

Country Status (8)

Country Link
JP (1) JP6310474B2 (lt)
EA (1) EA028031B1 (lt)
ES (1) ES2643902T3 (lt)
HR (1) HRP20171573T1 (lt)
HU (1) HUE036665T2 (lt)
LT (1) LT2928896T (lt)
MA (1) MA38100A1 (lt)
SI (1) SI2928896T1 (lt)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110172217A1 (en) * 2008-09-05 2011-07-14 Shionogi & Co., Ltd. Ring-fused morpholine derivative having pi3k-inhibiting activity
JO3398B1 (ar) * 2011-12-22 2019-10-20 Novartis Ag مشتقات 2،3- ثانى هيدرو- بنزو[1,4] أوكسازين والمركبات المتعلقة بها كمثبطات كيناز فسفواينوسيتيد-3 (pi3k) لمعالجة على سبيل المثال التهاب المفاصل الروماتيدي

Also Published As

Publication number Publication date
JP2016502531A (ja) 2016-01-28
MA38100A1 (fr) 2017-12-29
EA028031B1 (ru) 2017-09-29
SI2928896T1 (sl) 2017-10-30
LT2928896T (lt) 2017-09-25
JP6310474B2 (ja) 2018-04-11
HUE036665T2 (hu) 2018-07-30
EA201591023A1 (ru) 2015-09-30
ES2643902T3 (es) 2017-11-27

Similar Documents

Publication Publication Date Title
EA201890852A1 (ru) Соли валбеназина и их полиморфы
BR112015021888A8 (pt) inibidores de dna-pk, seus usos e composição farmacêutica
BR112015015468B8 (pt) Composto, e, composição farmacêutica
CL2008001632A1 (es) Compuestos derivados de acidos benzoilamino-indan-2-carboxilicos sustituidos, inhibidores del receptor cxcr5; composicion farmaceutica; y su uso en el tratamiento de efecciones fisiologicas inflamatorias, tales como artritis reumatoidea y asma.
BR112013013167A8 (pt) inibidores de bromodomínio e usos dos mesmos
CL2014001664A1 (es) Compuestos derivados de 2-([1,4]dioxan-2-ilmetoxi)-6,7-dihidropirimido[6,1-a]isoquinolin-4-ona, antagonistas del receptor gpr84; composicion farmaceutica; metodo de tratamiento o profilaxis; y uso en el tratamiento o profilaxis de afecciones inflamatorias tales como artritis reumatoide, vasculitis, asma y psoriasis, entre otras.
CL2007002708A1 (es) Compuestos derivados de pirrolo[2,3-b]piridina; procedimiento de preparacion; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como cancer, caquexia, trastornos inflamatorios, entre otros.
CR20130339A (es) Nuevos derivados heterocíclicos y su uso en el tratamiento de desordenes neurológicos
BR112016011484A2 (pt) Derivados de imidazopirimidina como moduladores de atividade de tnf
NZ618734A (en) Polyunsaturated fatty acids for the treatment of diseases related to cardiovascular, metabolic and inflammatory disease areas
HK1202450A1 (zh) 表現出抗癌和抗增殖活性的吡啶酮酰胺以及類似物
IN2014DN09352A (lt)
EA201200951A1 (ru) Определенные триазолопиридины и триазолопиразины, их композиции и способы их применения
CL2011000668A1 (es) Compuestos derivados de pirazolopiridina; proceso de preparacion; composicion farmaceutica y uso en el tratamiento de enfermedades tales como artritis reumatoide, psoriasis, esclerosis multiple, entre otras.
BRPI0916286B8 (pt) amidofenóxi-indazóis úteis como inibidores de c-met, seus usos, e composição farmacêutica
EA201490152A1 (ru) Антагонисты trpm8 и их применение при лечении
WO2015079010A3 (en) Pharmaceutical composition comprising lacosamide and levetiracetam
CR20160155A (es) Tienouracilcarboxamidas cíclicas y usos de las mismas
TR201005325A2 (tr) Atorvastatin ve aspirin içeren farmasötik formülasyonlar
WO2014014794A3 (en) Mineralocorticoid receptor antagonists
CL2013001445A1 (es) Compuestos derivados de difenilamina; composicion farmaceutica y uso en el tratamiento de enfermedades inflamatorias, tales como cancer.
PH12015501052A1 (en) Solid form of dihydro-pyrido-oxazine drivative
HRP20171573T1 (hr) Čvrsti oblik derivata dihidro-pirido-oksazina
CL2013002832A1 (es) Compuestos derivados del acido 7-(heteroaril-amino)-6,7,8,9-tetrahidropirido[1,2-a]indol acetico, moduladores del receptor de prostaglandina d2; composicion farmaceutica; y uso en la prevencion y el tratamiento de enfermedades alergicas e inmunes tales como asma.
WO2015031198A3 (en) Bendamustine pharmaceutical compositions